1. Home
  2. LEDS vs BIVI Comparison

LEDS vs BIVI Comparison

Compare LEDS & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.96

Market Cap

15.5M

Sector

Technology

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.42

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
BIVI
Founded
2005
2013
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
14.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
LEDS
BIVI
Price
$1.96
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
61.7K
Earning Date
01-09-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.21
$1.25
52 Week High
$3.37
$27.00

Technical Indicators

Market Signals
Indicator
LEDS
BIVI
Relative Strength Index (RSI) 37.45 42.45
Support Level $1.80 $1.45
Resistance Level $2.00 $1.63
Average True Range (ATR) 0.17 0.09
MACD -0.01 0.02
Stochastic Oscillator 13.93 35.90

Price Performance

Historical Comparison
LEDS
BIVI

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: